Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
OQO — Predicate Candidate Screening
12 FDA 510(k) clearances under this product code; the 50 most recent screened below.
96 daysmedian FDA review time
191 days90th percentile
12clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K172509 | Sentosa SA201 HSV 1/2 Qualitative PCR Test | Vela Diagnostics USA, Inc. | 2018-02-01 | 164 | 0 |
| K162673 | Aptima Herpes Simplex Viruses 1 & 2 Assay | Hologic, Inc. | 2017-06-15 | 262 | 0 |
| K150962 | Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Contr | Focus Diagnostics | 2015-08-28 | 140 | 2 |
| K150617 | cobas HSV 1 and 2 Test | Roche Molecular Systems, Inc. | 2015-06-01 | 83 | 0 |
| K142156 | SEEGENE ANYPLEX II HSV-1/2 ASSAY | Seegene | 2015-02-13 | 191 | 0 |
| K142738 | artus HSV-1/2 QS-RGQ MDx Kit | Qiagen | 2014-12-19 | 87 | 0 |
| K140198 | IMDX HSV-1/2 FOR ABBOTT M2000 | Intelligent Medical Devices, Inc. | 2014-05-13 | 106 | 0 |
| K140029 | AMIPLIVUE HSV 1&2 ASSAY | Quidel Corporation | 2014-03-26 | 79 | 0 |
| K111951 | ISOAMP HSV ASSAY | Biohelix Corporation | 2011-09-27 | 81 | 0 |
| K111527 | MULTICODE-RTX HERPES SIMPLEX VIRUS 1 & 2 KIT | Eragen Biosciences, Inc. | 2011-08-03 | 63 | 0 |
| K103798 | BD PROBETEC HERPES SIMPLEX VIRUSES (HSV 1& 2) Q AMPLIFIED DN | Becton, Dickinson & CO | 2011-03-18 | 81 | 0 |
| K100336 | MULTICODE - RTX HERPES SIMPLEX VIRUS 1 AND 2 KIT, MODEL 3711 | Eragen Biosciences | 2010-05-12 | 96 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda